{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:39:14Z","timestamp":1787002754598,"version":"build-2736575974"},"reference-count":281,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100001245","name":"The Jeffrey Modell Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001245","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1038\/s41423-020-00520-8","type":"journal-article","created":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T02:03:31Z","timestamp":1597629811000},"page":"588-603","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Beyond monogenetic rare variants: tackling the low rate of genetic diagnoses in predominantly antibody deficiency"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0240-4370","authenticated-orcid":false,"given":"Emily S. J.","family":"Edwards","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5851-9751","authenticated-orcid":false,"given":"Julian J.","family":"Bosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2129-1866","authenticated-orcid":false,"given":"Samar","family":"Ojaimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3489-7595","authenticated-orcid":false,"given":"Robyn E.","family":"O\u2019Hehir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4161-1919","authenticated-orcid":false,"given":"Menno C.","family":"van Zelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,17]]},"reference":[{"key":"520_CR1","doi-asserted-by":"crossref","unstructured":"Kobrynski, L., Powell, R. W. & Bowen, S. Prevalence and morbidity of primary immunodeficiency diseases, United States 2001\u20132007. J. Clin. Immunol. 34, 954\u2013961 (2014).","DOI":"10.1007\/s10875-014-0102-8"},{"key":"520_CR2","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1002\/eji.201444669","volume":"44","author":"C Picard","year":"2014","unstructured":"Picard, C. & Fischer, A. Contribution of high-throughput DNA sequencing to the study of primary immunodeficiencies. Eur. J. Immunol. 44, 2854\u20132861 (2014).","journal-title":"Eur. J. Immunol."},{"key":"520_CR3","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.jaci.2018.07.013","volume":"143","author":"G Bucciol","year":"2019","unstructured":"Bucciol, G. et al. Lessons learned from the study of human inborn errors of innate immunity. J. Allergy Clin. Immunol. 143, 507\u2013527 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","volume":"40","author":"SG Tangye","year":"2020","unstructured":"Tangye, S. G. et al. Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. J. Clin. Immunol.\u00a040, 66\u201381 (2020).","journal-title":"J. Clin. Immunol."},{"key":"520_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","volume":"40","author":"A Bousfiha","year":"2020","unstructured":"Bousfiha, A. et al. Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification. J. Clin. Immunol. 40, 66\u201381 (2020).","journal-title":"J. Clin. Immunol."},{"issue":"Suppl 1","key":"520_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2249.2009.03954.x","volume":"157","author":"B Gathmann","year":"2009","unstructured":"Gathmann, B. et al. The European internet-based patient and research database for primary immunodeficiencies: results 2006-2008. Clin. Exp. Immunol. 157(Suppl 1), 3\u201311 (2009).","journal-title":"Clin. Exp. Immunol."},{"key":"520_CR7","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nri3466","volume":"13","author":"A Durandy","year":"2013","unstructured":"Durandy, A., Kracker, S. & Fischer, A. Primary antibody deficiencies. Nat. Rev. Immunol. 13, 519\u2013533 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"520_CR8","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.jaci.2010.02.040","volume":"125","author":"M Lucas","year":"2010","unstructured":"Lucas, M. et al. Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. J. Allergy Clin. Immunol. 125, 1354\u20131360.e1354 (2010).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR9","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/jmedgenet-2015-103690","volume":"53","author":"DJ Bogaert","year":"2016","unstructured":"Bogaert, D. J. et al. Genes associated with common variable immunodeficiency: one diagnosis to rule them all? J. Med. Genet. 53, 575\u2013590 (2016).","journal-title":"J. Med. Genet."},{"key":"520_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.gendis.2019.10.002","volume":"7","author":"V Aggarwal","year":"2020","unstructured":"Aggarwal, V., Banday, A. Z., Jindal, A. K., Das, J. & Rawat, A. Recent advances in elucidating the genetics of common variable immunodeficiency. Genes Dis. 7, 26\u201337 (2020).","journal-title":"Genes Dis."},{"key":"520_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","volume":"4","author":"FA Bonilla","year":"2016","unstructured":"Bonilla, F. A. et al. International Consensus Document (ICON): common variable immunodeficiency disorders. J. Allergy Clin. Immunol. Pract. 4, 38\u201359 (2016).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"520_CR12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/0092-8674(93)90667-F","volume":"72","author":"S Tsukada","year":"1993","unstructured":"Tsukada, S. et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72, 279\u2013290 (1993).","journal-title":"Cell"},{"key":"520_CR13","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/361226a0","volume":"361","author":"D Vetrie","year":"1993","unstructured":"Vetrie, D. et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 361, 226\u2013233 (1993).","journal-title":"Nature"},{"key":"520_CR14","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/0140-6736(93)93172-W","volume":"341","author":"I Vorechovsky","year":"1993","unstructured":"Vorechovsky, I. et al. Molecular diagnosis of X-linked agammaglobulinaemia. Lancet 341, 1153 (1993).","journal-title":"Lancet"},{"key":"520_CR15","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1084\/jem.193.10.1169","volume":"193","author":"GM Dingjan","year":"2001","unstructured":"Dingjan, G. M. et al. Bruton\u2019s tyrosine kinase regulates the activation of gene rearrangements at the lambda light chain locus in precursor B cells in the mouse. J. Exp. Med. 193, 1169\u20131178 (2001).","journal-title":"J. Exp. Med"},{"key":"520_CR16","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1182\/blood.2019003299","volume":"135","author":"O Papapietro","year":"2020","unstructured":"Papapietro, O. et al. Topoisomerase 2beta mutation impairs early B cell development. Blood 135, 1497\u20131501 (2020).","journal-title":"Blood"},{"key":"520_CR17","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.jaci.2017.04.037","volume":"140","author":"M Ben-Ali","year":"2017","unstructured":"Ben-Ali, M. et al. Homozygous transcription factor 3 gene (TCF3) mutation is associated with severe hypogammaglobulinemia and B-cell acute lymphoblastic leukemia. J. Allergy Clin. Immunol. 140, 1191\u20131194.e1194 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR18","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.clim.2018.07.016","volume":"198","author":"S Qureshi","year":"2019","unstructured":"Qureshi, S., Sheikh, M. D. A. & Qamar, F. N. Autosomal recessive agammaglobulinemia\u2014first case with a novel TCF3 mutation from Pakistan. Clin. Immunol. 198, 100\u2013101 (2019).","journal-title":"Clin. Immunol."},{"key":"520_CR19","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1056\/NEJMoa1512234","volume":"374","author":"HS Kuehn","year":"2016","unstructured":"Kuehn, H. S. et al. Loss of B Cells in Patients with Heterozygous Mutations in IKAROS. N. Engl. J. Med. 374, 1032\u20131043 (2016).","journal-title":"N. Engl. J. Med."},{"key":"520_CR20","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1056\/NEJM199611143352003","volume":"335","author":"L Yel","year":"1996","unstructured":"Yel, L. et al. Mutations in the mu heavy-chain gene in patients with agammaglobulinemia. N. Engl. J. Med. 335, 1486\u20131493 (1996).","journal-title":"N. Engl. J. Med"},{"key":"520_CR21","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1172\/JCI7696","volume":"104","author":"Y Minegishi","year":"1999","unstructured":"Minegishi, Y. et al. Mutations in Igalpha (CD79a) result in a complete block in B-cell development. J. Clin. Investig. 104, 1115\u20131121 (1999).","journal-title":"J. Clin. Investig."},{"key":"520_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1084\/jem.187.1.71","volume":"187","author":"Y Minegishi","year":"1998","unstructured":"Minegishi, Y. et al. Mutations in the human lambda5\/14.1 gene result in B cell deficiency and agammaglobulinemia. J. Exp. Med. 187, 71\u201377 (1998).","journal-title":"J. Exp. Med."},{"key":"520_CR23","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1126\/science.286.5446.1954","volume":"286","author":"Y Minegishi","year":"1999","unstructured":"Minegishi, Y. et al. An essential role for BLNK in human B cell development. Science 286, 1954\u20131957 (1999).","journal-title":"Science"},{"key":"520_CR24","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.4049\/jimmunol.179.4.2055","volume":"179","author":"AK Dobbs","year":"2007","unstructured":"Dobbs, A. K. et al. Cutting edge: a hypomorphic mutation in Igbeta (CD79b) in a patient with immunodeficiency and a leaky defect in B cell development. J. Immunol. 179, 2055\u20132059 (2007).","journal-title":"J. Immunol."},{"key":"520_CR25","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41590-018-0295-8","volume":"20","author":"C Anzilotti","year":"2019","unstructured":"Anzilotti, C. et al. An essential role for the Zn(2+) transporter ZIP7 in B cell development. Nat. Immunol. 20, 350\u2013361 (2019).","journal-title":"Nat. Immunol."},{"key":"520_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11570-6","volume":"10","author":"L Broderick","year":"2019","unstructured":"Broderick, L. et al. Mutations in topoisomerase IIbeta result in a B cell immunodeficiency. Nat. Commun. 10, 3644 (2019).","journal-title":"Nat. Commun."},{"key":"520_CR27","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.4049\/jimmunol.168.7.3376","volume":"168","author":"BA Croker","year":"2002","unstructured":"Croker, B. A. et al. The Rac2 guanosine triphosphatase regulates B lymphocyte antigen receptor responses and chemotaxis and is required for establishment of B-1a and marginal zone B lymphocytes. J. Immunol. 168, 3376\u20133386 (2002).","journal-title":"J. Immunol."},{"key":"520_CR28","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.jaci.2014.10.039","volume":"135","author":"O Alkhairy","year":"2015","unstructured":"Alkhairy, O. K. et al. RAC2 loss-of-function mutation in 2 siblings with characteristics of common variable immunodeficiency. J. Allergy Clin. Immunol. 135, 1380\u20131384.e1-5 (2015).","journal-title":"J. Allergy Clin. Immunol"},{"key":"520_CR29","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jaci.2016.03.022","volume":"138","author":"E Elkaim","year":"2016","unstructured":"Elkaim, E. et al. Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase delta syndrome 2: a cohort study. J. Allergy Clin. Immunol. 138, 210\u2013218.e219 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR30","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.jaci.2018.06.039","volume":"142","author":"G Sogkas","year":"2018","unstructured":"Sogkas, G. et al. Primary immunodeficiency disorder caused by phosphoinositide 3-kinase delta deficiency. J. Allergy Clin. Immunol. 142, 1650\u20131653 e1652 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR31","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.jaci.2018.10.005","volume":"143","author":"SB Cohen","year":"2019","unstructured":"Cohen, S. B. et al. Human primary immunodeficiency caused by expression of a kinase-dead p110delta mutant. J. Allergy Clin. Immunol. 143, 797\u2013799 e792 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR32","doi-asserted-by":"crossref","unstructured":"Ramadani, F. et al. The PI3K isoforms p110alpha and p110delta are essential for pre-B cell receptor signaling and B cell development. Sci. Signal. 3, ra60 (2010).","DOI":"10.1126\/scisignal.2001104"},{"key":"520_CR33","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1084\/jem.20112533","volume":"209","author":"ME Conley","year":"2012","unstructured":"Conley, M. E. et al. Agammaglobulinemia and absent B lineage cells in a patient lacking the p85alpha subunit of PI3K. J. Exp. Med 209, 463\u2013470 (2012).","journal-title":"J. Exp. Med"},{"key":"520_CR34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s10875-017-0462-y","volume":"38","author":"P Tang","year":"2018","unstructured":"Tang, P. et al. Autosomal recessive agammaglobulinemia due to a homozygous mutation in PIK3R1. J. Clin. Immunol. 38, 88\u201395 (2018).","journal-title":"J. Clin. Immunol."},{"key":"520_CR35","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1084\/jem.20070264","volume":"204","author":"S Ferrari","year":"2007","unstructured":"Ferrari, S. et al. Mutations of the Igbeta gene cause agammaglobulinemia in man. J. Exp. Med. 204, 2047\u20132051 (2007).","journal-title":"J. Exp. Med."},{"key":"520_CR36","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.ajhg.2007.10.011","volume":"82","author":"MC van Zelm","year":"2008","unstructured":"van Zelm, M. C. et al. Gross deletions involving IGHM, BTK, or Artemis: a model for genomic lesions mediated by transposable elements. Am. J. Hum. Genet. 82, 320\u2013332 (2008).","journal-title":"Am. J. Hum. Genet."},{"key":"520_CR37","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3389\/fimmu.2014.00415","volume":"5","author":"R Ameratunga","year":"2014","unstructured":"Ameratunga, R. et al. Comparison of diagnostic criteria for common variable immunodeficiency disorder. Front. Immunol. 5, 415 (2014).","journal-title":"Front. Immunol."},{"key":"520_CR38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jaut.2010.10.002","volume":"36","author":"J Boileau","year":"2011","unstructured":"Boileau, J. et al. Autoimmunity in common variable immunodeficiency: correlation with lymphocyte phenotype in the French DEFI study. J. Autoimmun. 36, 25\u201332 (2011).","journal-title":"J. Autoimmun."},{"key":"520_CR39","unstructured":"Immunodeficiencies, E. S. F. New Clinical Diagnosis Criteria for the ESID Registry. Geneva. https:\/\/esid.org\/Working-Parties\/Registry\/Diagnosis-criteria (2017)."},{"key":"520_CR40","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1006\/clim.1999.4799","volume":"93","author":"ME Conley","year":"1999","unstructured":"Conley, M. E., Notarangelo, L. D. & Etzioni, A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin. Immunol. 93, 190\u2013197 (1999).","journal-title":"Clin. Immunol."},{"key":"520_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.clim.2019.04.001","volume":"203","author":"C von Spee-Mayer","year":"2019","unstructured":"von Spee-Mayer, C. et al. Evaluating laboratory criteria for combined immunodeficiency in adult patients diagnosed with common variable immunodeficiency. Clin. Immunol. 203, 59\u201362 (2019).","journal-title":"Clin. Immunol."},{"key":"520_CR42","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.jaip.2016.07.002","volume":"4","author":"R Bertinchamp","year":"2016","unstructured":"Bertinchamp, R. et al. Exclusion of patients with a severe T-cell defect improves the definition of common variable immunodeficiency. J. Allergy Clin. Immunol. Pract. 4, 1147\u20131157 (2016).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"520_CR43","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.jaip.2016.09.006","volume":"4","author":"H Chapel","year":"2016","unstructured":"Chapel, H. Common variable immunodeficiency disorders (CVID)\u2014diagnoses of exclusion, especially combined immune defects. J. Allergy Clin. Immunol. Pr. 4, 1158\u20131159 (2016).","journal-title":"J. Allergy Clin. Immunol. Pr."},{"key":"520_CR44","doi-asserted-by":"publisher","first-page":"e1130","DOI":"10.1002\/cti2.1130","volume":"9","author":"C Grosserichter-Wagener","year":"2020","unstructured":"Grosserichter-Wagener, C. et al. Defective formation of IgA memory B cells, Th1 and Th17 cells in symptomatic patients with selective IgA deficiency. Clin. Transl. Immunol. 9, e1130 (2020).","journal-title":"Clin. Transl. Immunol."},{"key":"520_CR45","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.3324\/haematol.2013.085076","volume":"98","author":"GJ Driessen","year":"2013","unstructured":"Driessen, G. J. et al. Common variable immunodeficiency and idiopathic primary hypogammaglobulinemia: two different conditions within the same disease spectrum. Haematologica 98, 1617\u20131623 (2013).","journal-title":"Haematologica"},{"key":"520_CR46","doi-asserted-by":"publisher","first-page":"S158","DOI":"10.1016\/j.jaci.2004.12.645","volume":"115","author":"YK Cheng","year":"2005","unstructured":"Cheng, Y. K., Decker, P. A., O\u2019Byrne, M. M. & Weiler, C. R. Specific polysaccharide antibody deficiency syndrome (SPAD): Clinical and laboratory characteristics of seventy seven patients. J. Allergy Clin. Immunol. 115, S158 (2005).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR47","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3346\/jkms.2010.25.6.824","volume":"25","author":"JH Kim","year":"2010","unstructured":"Kim, J. H. et al. Immunoglobulin G subclass deficiency is the major phenotype of primary immunodeficiency in a Korean adult cohort. J. Korean Med. Sci. 25, 824\u2013828 (2010).","journal-title":"J. Korean Med. Sci."},{"key":"520_CR48","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","volume":"119","author":"ES Resnick","year":"2012","unstructured":"Resnick, E. S., Moshier, E. L., Godbold, J. H. & Cunningham-Rundles, C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood 119, 1650\u20131657 (2012).","journal-title":"Blood"},{"issue":"Suppl 1","key":"520_CR49","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/cei.12516","volume":"178","author":"S Jolles","year":"2014","unstructured":"Jolles, S. Subclinical infection and dosing in primary immunodeficiencies. Clin. Exp. Immunol. 178(Suppl 1), 67\u201369 (2014).","journal-title":"Clin. Exp. Immunol."},{"key":"520_CR50","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.3389\/fimmu.2019.02593","volume":"10","author":"ESJ Edwards","year":"2019","unstructured":"Edwards, E. S. J. et al. Predominantly antibody-deficient patients with non-infectious complications have reduced naive B, Treg, Th17, and Tfh17 cells. Front. Immunol. 10, 2593 (2019).","journal-title":"Front. Immunol."},{"key":"520_CR51","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3389\/fimmu.2018.00694","volume":"9","author":"CA Slade","year":"2018","unstructured":"Slade, C. A. et al. Delayed diagnosis and complications of predominantly antibody deficiencies in a cohort of australian adults. Front. Immunol. 9, 694 (2018).","journal-title":"Front. Immunol."},{"key":"520_CR52","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","volume":"112","author":"H Chapel","year":"2008","unstructured":"Chapel, H. et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 112, 277\u2013286 (2008).","journal-title":"Blood"},{"key":"520_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0941-0","volume":"13","author":"I Odnoletkova","year":"2018","unstructured":"Odnoletkova, I. et al. The burden of common variable immunodeficiency disorders: a retrospective analysis of the European Society for Immunodeficiency (ESID) registry data. Orphanet J. Rare Dis. 13, 201 (2018).","journal-title":"Orphanet J. Rare Dis."},{"key":"520_CR54","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jaci.2018.06.012","volume":"143","author":"N Romberg","year":"2019","unstructured":"Romberg, N. et al. Patients with common variable immunodeficiency with autoimmune cytopenias exhibit hyperplastic yet inefficient germinal center responses. J. Allergy Clin. Immunol. 143, 258\u2013265 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR55","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1182\/blood.V99.5.1544","volume":"99","author":"K Warnatz","year":"2002","unstructured":"Warnatz, K. et al. Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 99, 1544\u20131551 (2002).","journal-title":"Blood"},{"key":"520_CR56","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","volume":"111","author":"C Wehr","year":"2008","unstructured":"Wehr, C. et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 111, 77\u201385 (2008).","journal-title":"Blood"},{"key":"520_CR57","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.jaci.2019.02.017","volume":"144","author":"E Blanco","year":"2019","unstructured":"Blanco, E. et al. Defects in memory B-cell and plasma cell subsets expressing different immunoglobulin-subclasses in patients with CVID and immunoglobulin subclass deficiencies. J. Allergy Clin. Immunol. 144, 809\u2013824 (2019).","journal-title":"J. Allergy Clin. Immunol"},{"key":"520_CR58","doi-asserted-by":"publisher","first-page":"6814","DOI":"10.1182\/blood-2011-06-361881","volume":"118","author":"GJ Driessen","year":"2011","unstructured":"Driessen, G. J. et al. B-cell replication history and somatic hypermutation status identify distinct pathophysiologic backgrounds in common variable immunodeficiency. Blood 118, 6814\u20136823 (2011).","journal-title":"Blood"},{"key":"520_CR59","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/cyto.b.20432","volume":"74","author":"K Warnatz","year":"2008","unstructured":"Warnatz, K. & Schlesier, M. Flowcytometric phenotyping of common variable immunodeficiency. Cytom. B Clin. Cytom. 74, 261\u2013271 (2008).","journal-title":"Cytom. B Clin. Cytom."},{"key":"520_CR60","first-page":"222","volume":"6","author":"M Ebbo","year":"2016","unstructured":"Ebbo, M. et al. Low circulating natural killer cell counts are associated with severe disease in patients with common variable immunodeficiency. EBio Med. 6, 222\u2013230 (2016).","journal-title":"EBio Med."},{"key":"520_CR61","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1046\/j.1365-2249.2000.01317.x","volume":"121","author":"RM Aspalter","year":"2000","unstructured":"Aspalter, R. M., Sewell, W. A., Dolman, K., Farrant, J. & Webster, A. D. Deficiency in circulating natural killer (NK) cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia. Clin. Exp. Immunol. 121, 506\u2013514 (2000).","journal-title":"Clin. Exp. Immunol."},{"key":"520_CR62","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.4049\/jimmunol.178.6.3932","volume":"178","author":"A Giovannetti","year":"2007","unstructured":"Giovannetti, A. et al. Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J. Immunol. 178, 3932\u20133943 (2007).","journal-title":"J. Immunol."},{"key":"520_CR63","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1365-2249.2012.04643.x","volume":"170","author":"EA Bateman","year":"2012","unstructured":"Bateman, E. A. et al. T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections. Clin. Exp. Immunol. 170, 202\u2013211 (2012).","journal-title":"Clin. Exp. Immunol."},{"key":"520_CR64","doi-asserted-by":"publisher","first-page":"4951587","DOI":"10.1155\/2016\/4951587","volume":"2016","author":"A Coraglia","year":"2016","unstructured":"Coraglia, A. et al. Common variable immunodeficiency and circulating TFH. J. Immunol. Res. 2016, 4951587 (2016).","journal-title":"J. Immunol. Res."},{"key":"520_CR65","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jaci.2017.04.041","volume":"141","author":"S Unger","year":"2018","unstructured":"Unger, S. et al. The TH1 phenotype of follicular helper T cells indicates an IFN-gamma-associated immune dysregulation in patients with CD21low common variable immunodeficiency. J. Allergy Clin. Immunol. 141, 730\u2013740 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR66","doi-asserted-by":"publisher","first-page":"AB162","DOI":"10.1016\/j.jaci.2013.12.586","volume":"133","author":"ND Romberg","year":"2014","unstructured":"Romberg, N. D., Hsu, I., Price, C. C., Cunningham-Rundles, C. & Meffre, E. Expansion of circulating T follicular helper cells in CVID patients with autoimmune cytopenias. J. Allergy Clin. Immunol. 133, AB162 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR67","doi-asserted-by":"publisher","first-page":"e22848","DOI":"10.1371\/journal.pone.0022848","volume":"6","author":"RR Barbosa","year":"2011","unstructured":"Barbosa, R. R. et al. Primary B-cell deficiencies reveal a link between human IL-17-producing CD4 T-cell homeostasis and B-cell differentiation. PLoS ONE 6, e22848 (2011).","journal-title":"PLoS ONE"},{"key":"520_CR68","doi-asserted-by":"publisher","first-page":"e6269","DOI":"10.1371\/journal.pone.0006269","volume":"4","author":"KM Melo","year":"2009","unstructured":"Melo, K. M. et al. A decreased frequency of regulatory T cells in patients with common variable immunodeficiency. PLoS ONE 4, e6269 (2009).","journal-title":"PLoS ONE"},{"key":"520_CR69","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s10875-009-9351-3","volume":"30","author":"G Arumugakani","year":"2010","unstructured":"Arumugakani, G., Wood, P. M. & Carter, C. R. Frequency of Treg cells is reduced in CVID patients with autoimmunity and splenomegaly and is associated with expanded CD21lo B lymphocytes. J. Clin. Immunol. 30, 292\u2013300 (2010).","journal-title":"J. Clin. Immunol."},{"key":"520_CR70","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1086\/606059","volume":"49","author":"M Malphettes","year":"2009","unstructured":"Malphettes, M. et al. Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clin. Infect. Dis. 49, 1329\u20131338 (2009).","journal-title":"Clin. Infect. Dis."},{"key":"520_CR71","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jaci.2020.01.046","volume":"146","author":"J Hultberg","year":"2020","unstructured":"Hultberg, J., Ernerudh, J., Larsson, M., Nilsdotter-Augustinsson, A. & Nystrom, S. Plasma protein profiling reflects TH1-driven immune dysregulation in common variable immunodeficiency. J. Allergy Clin. Immunol. 146, 417\u2013428 (2020).","journal-title":"J. Allergy Clin. Immunol"},{"key":"520_CR72","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.jaci.2015.09.013","volume":"137","author":"M Cols","year":"2016","unstructured":"Cols, M. et al. Expansion of inflammatory innate lymphoid cells in patients with common variable immune deficiency. J. Allergy Clin. Immunol. 137, 1206\u20131215 e1206 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR73","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1749-6632.2011.06278.x","volume":"1246","author":"MA Berkowska","year":"2011","unstructured":"Berkowska, M. A., van der Burg, M., van Dongen, J. J. & van Zelm, M. C. Checkpoints of B cell differentiation: visualizing Ig-centric processes. Ann. N.Y. Acad. Sci. 1246, 11\u201325 (2011).","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"520_CR74","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nri3570","volume":"14","author":"MR Clark","year":"2014","unstructured":"Clark, M. R., Mandal, M., Ochiai, K. & Singh, H. Orchestrating B cell lymphopoiesis through interplay of IL-7 receptor and pre-B cell receptor signalling. Nat. Rev. Immunol. 14, 69\u201380 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"520_CR75","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.1172\/JCI71927","volume":"123","author":"B Boisson","year":"2013","unstructured":"Boisson, B. et al. A recurrent dominant negative E47 mutation causes agammaglobulinemia and BCR(-) B cells. J. Clin. Investig. 123, 4781\u20134785 (2013).","journal-title":"J. Clin. Investig."},{"key":"520_CR76","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1006\/clim.1998.4629","volume":"90","author":"J Rohrer","year":"1999","unstructured":"Rohrer, J., Minegishi, Y., Richter, D., Eguiguren, J. & Conley, M. E. Unusual mutations in Btk: an insertion, a duplication, an inversion, and four large deletions. Clin. Immunol. 90, 28\u201337 (1999).","journal-title":"Clin. Immunol."},{"key":"520_CR77","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/(SICI)1098-1004(1999)13:4<280::AID-HUMU3>3.0.CO;2-L","volume":"13","author":"M Vihinen","year":"1999","unstructured":"Vihinen, M. et al. Mutations of the human BTK gene coding for bruton tyrosine kinase in X-linked agammaglobulinemia. Hum. Mutat. 13, 280\u2013285 (1999).","journal-title":"Hum. Mutat."},{"key":"520_CR78","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s12185-019-02614-0","volume":"109","author":"E Kumaki","year":"2019","unstructured":"Kumaki, E. et al. Atypical SIFD with novel TRNT1 mutations: a case study on the pathogenesis of B-cell deficiency. Int. J. Hematol. 109, 382\u2013389 (2019).","journal-title":"Int. J. Hematol."},{"key":"520_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-016-0477-0","volume":"11","author":"Y Wedatilake","year":"2016","unstructured":"Wedatilake, Y. et al. TRNT1 deficiency: clinical, biochemical and molecular genetic features. Orphanet J. Rare Dis. 11, 90 (2016).","journal-title":"Orphanet J. Rare Dis."},{"key":"520_CR80","doi-asserted-by":"publisher","first-page":"11554","DOI":"10.1073\/pnas.1102600108","volume":"108","author":"G Meyers","year":"2011","unstructured":"Meyers, G. et al. Activation-induced cytidine deaminase (AID) is required for B-cell tolerance in humans. Proc. Natl Acad. Sci. USA 108, 11554\u201311559 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"520_CR81","doi-asserted-by":"publisher","first-page":"13945","DOI":"10.1073\/pnas.0903543106","volume":"106","author":"K Warnatz","year":"2009","unstructured":"Warnatz, K. et al. B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc. Natl Acad. Sci. USA 106, 13945\u201313950 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"520_CR82","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s10875-005-5637-2","volume":"25","author":"CG Losi","year":"2005","unstructured":"Losi, C. G. et al. Mutational analysis of human BAFF receptor TNFRSF13C (BAFF-R) in patients with common variable immunodeficiency. J. Clin. Immunol. 25, 496\u2013502 (2005).","journal-title":"J. Clin. Immunol."},{"key":"520_CR83","doi-asserted-by":"publisher","first-page":"5127","DOI":"10.1073\/pnas.1221211110","volume":"110","author":"HY Wang","year":"2013","unstructured":"Wang, H. Y. et al. Antibody deficiency associated with an inherited autosomal dominant mutation in TWEAK. Proc. Natl Acad. Sci. USA 110, 5127\u20135132 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"520_CR84","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S1074-7613(01)00098-X","volume":"14","author":"A Cherukuri","year":"2001","unstructured":"Cherukuri, A., Cheng, P. C., Sohn, H. W. & Pierce, S. K. The CD19\/CD21 complex functions to prolong B cell antigen receptor signaling from lipid rafts. Immunity 14, 169\u2013179 (2001).","journal-title":"Immunity"},{"key":"520_CR85","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1126\/science.1373518","volume":"256","author":"RH Carter","year":"1992","unstructured":"Carter, R. H. & Fearon, D. T. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256, 105\u2013107 (1992).","journal-title":"Science"},{"key":"520_CR86","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/0167-5699(93)90316-D","volume":"14","author":"CJ van Noesel","year":"1993","unstructured":"van Noesel, C. J., Lankester, A. C. & van Lier, R. A. Dual antigen recognition by B cells. Immunol. Today 14, 8\u201311 (1993).","journal-title":"Immunol. Today"},{"key":"520_CR87","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jaci.2013.11.015","volume":"134","author":"MC van Zelm","year":"2014","unstructured":"van Zelm, M. C. et al. Human CD19 and CD40L deficiencies impair antibody selection and differentially affect somatic hypermutation. J. Allergy Clin. Immunol. 134, 135\u2013144 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR88","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1172\/JCI39748","volume":"120","author":"MC van Zelm","year":"2010","unstructured":"van Zelm, M. C. et al. CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. J. Clin. Investig. 120, 1265\u20131274 (2010).","journal-title":"J. Clin. Investig."},{"key":"520_CR89","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1093\/hmg\/ddr068","volume":"20","author":"MC van Zelm","year":"2011","unstructured":"van Zelm, M. C. et al. Antibody deficiency due to a missense mutation in CD19 demonstrates the importance of the conserved tryptophan 41 in immunoglobulin superfamily domain formation. Hum. Mol. Genet. 20, 1854\u20131863 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"520_CR90","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.clim.2015.08.010","volume":"161","author":"MW Wentink","year":"2015","unstructured":"Wentink, M. W. et al. CD21 and CD19 deficiency: two defects in the same complex leading to different disease modalities. Clin. Immunol. 161, 120\u2013127 (2015).","journal-title":"Clin. Immunol."},{"key":"520_CR91","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.jaci.2011.09.027","volume":"129","author":"J Thiel","year":"2012","unstructured":"Thiel, J. et al. Genetic CD21 deficiency is associated with hypogammaglobulinemia. J. Allergy Clin. Immunol. 129, 801\u2013810 e806 (2012).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11600","volume":"7","author":"EJ Jansen","year":"2016","unstructured":"Jansen, E. J. et al. ATP6AP1 deficiency causes an immunodeficiency with hepatopathy, cognitive impairment and abnormal protein glycosylation. Nat. Commun. 7, 11600 (2016).","journal-title":"Nat. Commun."},{"key":"520_CR93","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1038\/emboj.2011.251","volume":"30","author":"T Oellerich","year":"2011","unstructured":"Oellerich, T. et al. The B-cell antigen receptor signals through a preformed transducer module of SLP65 and CIN85. EMBO J. 30, 3620\u20133634 (2011).","journal-title":"EMBO J."},{"key":"520_CR94","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1084\/jem.20170534","volume":"215","author":"B Keller","year":"2018","unstructured":"Keller, B. et al. Germline deletion of CIN85 in humans with X chromosome-linked antibody deficiency. J. Exp. Med. 215, 1327\u20131336 (2018).","journal-title":"J. Exp. Med."},{"key":"520_CR95","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1056\/NEJMoa051568","volume":"354","author":"MC van Zelm","year":"2006","unstructured":"van Zelm, M. C. et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N. Engl. J. Med. 354, 1901\u20131912 (2006).","journal-title":"N. Engl. J. Med."},{"key":"520_CR96","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1172\/JCI40231","volume":"120","author":"TW Kuijpers","year":"2010","unstructured":"Kuijpers, T. W. et al. CD20 deficiency in humans results in impaired T cell-independent antibody responses. J. Clin. Investig. 120, 214\u2013222 (2010).","journal-title":"J. Clin. Investig."},{"key":"520_CR97","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1084\/jem.20120831","volume":"209","author":"AL Snow","year":"2012","unstructured":"Snow, A. L. et al. Congenital B cell lymphocytosis explained by novel germline CARD11 mutations. J. Exp. Med. 209, 2247\u20132261 (2012).","journal-title":"J. Exp. Med."},{"key":"520_CR98","doi-asserted-by":"publisher","first-page":"18545","DOI":"10.1074\/jbc.M800784200","volume":"283","author":"MJ Polyak","year":"2008","unstructured":"Polyak, M. J., Li, H., Shariat, N. & Deans, J. P. CD20 homo-oligomers physically associate with the B cell antigen receptor. Dissociation upon receptor engagement and recruitment of phosphoproteins and calmodulin-binding proteins. J. Biol. Chem. 283, 18545\u201318552 (2008).","journal-title":"J. Biol. Chem."},{"key":"520_CR99","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.4049\/jimmunol.169.6.2886","volume":"169","author":"RJ Petrie","year":"2002","unstructured":"Petrie, R. J. & Deans, J. P. Colocalization of the B cell receptor and CD20 followed by activation-dependent dissociation in distinct lipid rafts. J. Immunol. 169, 2886\u20132891 (2002).","journal-title":"J. Immunol."},{"key":"520_CR100","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3389\/fimmu.2016.00225","volume":"7","author":"J Kranich","year":"2016","unstructured":"Kranich, J. & Krautler, N. J. How follicular dendritic cells shape the B-Cell antigenome. Front. Immunol. 7, 225 (2016).","journal-title":"Front. Immunol."},{"key":"520_CR101","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1146\/annurev.iy.12.040194.001001","volume":"12","author":"IC MacLennan","year":"1994","unstructured":"MacLennan, I. C. Germinal centers. Annu. Rev. Immunol. 12, 117\u2013139 (1994).","journal-title":"Annu. Rev. Immunol."},{"key":"520_CR102","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1385\/IR:24:3:311","volume":"24","author":"A Bhushan","year":"2001","unstructured":"Bhushan, A. & Covey, L. R. CD40:CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes. Immunol. Res. 24, 311\u2013324 (2001).","journal-title":"Immunol. Res."},{"key":"520_CR103","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000236923","volume":"107","author":"E Castigli","year":"1995","unstructured":"Castigli, E. et al. CD40 ligand\/CD40 deficiency. Int. Arch. Allergy Immunol. 107, 37\u201339 (1995).","journal-title":"Int. Arch. Allergy Immunol."},{"key":"520_CR104","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.jaci.2014.12.1940","volume":"136","author":"J Chou","year":"2015","unstructured":"Chou, J. et al. A novel mutation in ICOS presenting as hypogammaglobulinemia with susceptibility to opportunistic pathogens. J. Allergy Clin. Immunol. 136, 794\u2013797.e791 (2015).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR105","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/ni902","volume":"4","author":"B Grimbacher","year":"2003","unstructured":"Grimbacher, B. et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat. Immunol. 4, 261\u2013268 (2003).","journal-title":"Nat. Immunol."},{"key":"520_CR106","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.clim.2004.07.002","volume":"113","author":"U Salzer","year":"2004","unstructured":"Salzer, U. et al. ICOS deficiency in patients with common variable immunodeficiency. Clin. Immunol. 113, 234\u2013240 (2004).","journal-title":"Clin. Immunol."},{"key":"520_CR107","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1182\/blood-2005-07-2955","volume":"107","author":"K Warnatz","year":"2006","unstructured":"Warnatz, K. et al. Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency. Blood 107, 3045\u20133052 (2006).","journal-title":"Blood"},{"key":"520_CR108","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1084\/jem.20180668","volume":"215","author":"L Roussel","year":"2018","unstructured":"Roussel, L. et al. Loss of human ICOSL results in combined immunodeficiency. J. Exp. Med. 215, 3151\u20133164 (2018).","journal-title":"J. Exp. Med."},{"key":"520_CR109","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0092-8674(00)00079-9","volume":"102","author":"P Revy","year":"2000","unstructured":"Revy, P. et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102, 565\u2013575 (2000).","journal-title":"Cell"},{"key":"520_CR110","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/ni974","volume":"4","author":"K Imai","year":"2003","unstructured":"Imai, K. et al. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat. Immunol. 4, 1023\u20131028 (2003).","journal-title":"Nat. Immunol."},{"key":"520_CR111","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.4049\/jimmunol.1102984","volume":"188","author":"P Gardes","year":"2012","unstructured":"Gardes, P. et al. Human MSH6 deficiency is associated with impaired antibody maturation. J. Immunol. 188, 2023\u20132029 (2012).","journal-title":"J. Immunol."},{"key":"520_CR112","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.jaci.2014.08.030","volume":"135","author":"S Kracker","year":"2015","unstructured":"Kracker, S. et al. An inherited immunoglobulin class-switch recombination deficiency associated with a defect in the INO80 chromatin remodeling complex. J. Allergy Clin. Immunol. 135, 998\u20131007 e1006 (2015).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR113","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/ng1601","volume":"37","author":"E Castigli","year":"2005","unstructured":"Castigli, E. et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat. Genet. 37, 829\u2013834 (2005).","journal-title":"Nat. Genet."},{"key":"520_CR114","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.clim.2007.04.012","volume":"124","author":"AK Knight","year":"2007","unstructured":"Knight, A. K. et al. High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency. Clin. Immunol. 124, 182\u2013189 (2007).","journal-title":"Clin. Immunol."},{"key":"520_CR115","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/ng0407-429","volume":"39","author":"Q Pan-Hammarstrom","year":"2007","unstructured":"Pan-Hammarstrom, Q. et al. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat. Genet. 39, 429\u2013430 (2007).","journal-title":"Nat. Genet"},{"key":"520_CR116","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.1172\/JCI69854","volume":"123","author":"N Romberg","year":"2013","unstructured":"Romberg, N. et al. CVID-associated TACI mutations affect autoreactive B cell selection and activation. J. Clin. Investig. 123, 4283\u20134293 (2013).","journal-title":"J. Clin. Investig."},{"key":"520_CR117","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1182\/blood-2008-02-141937","volume":"113","author":"U Salzer","year":"2009","unstructured":"Salzer, U. et al. Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood 113, 1967\u20131976 (2009).","journal-title":"Blood"},{"key":"520_CR118","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/ng1600","volume":"37","author":"U Salzer","year":"2005","unstructured":"Salzer, U. et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat. Genet. 37, 820\u2013828 (2005).","journal-title":"Nat. Genet."},{"key":"520_CR119","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.jaci.2007.10.001","volume":"120","author":"L Zhang","year":"2007","unstructured":"Zhang, L. et al. Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes. J. Allergy Clin. Immunol. 120, 1178\u20131185 (2007).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR120","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/eji.201242945","volume":"43","author":"MB Almejun","year":"2013","unstructured":"Almejun, M. B. et al. Naturally occurring mutation affecting the MyD88-binding site of TNFRSF13B impairs triggering of class switch recombination. Eur. J. Immunol. 43, 805\u2013814 (2013).","journal-title":"Eur. J. Immunol."},{"key":"520_CR121","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.jaci.2019.03.016","volume":"143","author":"O Scott","year":"2019","unstructured":"Scott, O. & Roifman, C. M. NF-kappaB pathway and the Goldilocks principle: Lessons from human disorders of immunity and inflammation. J. Allergy Clin. Immunol. 143, 1688\u20131701 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR122","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s10875-019-00612-9","volume":"39","author":"SG Tangye","year":"2019","unstructured":"Tangye, S. G. et al. Immune dysregulation and disease pathogenesis due to activating mutations in PIK3CD-the Goldilocks\u2019 effect. J. Clin. Immunol. 39, 148\u2013158 (2019).","journal-title":"J. Clin. Immunol."},{"key":"520_CR123","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1172\/JCI75746","volume":"124","author":"MC Deau","year":"2014","unstructured":"Deau, M. C. et al. A human immunodeficiency caused by mutations in the PIK3R1 gene. J. Clin. Investig. 124, 3923\u20133928 (2014).","journal-title":"J. Clin. Investig."},{"key":"520_CR124","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1084\/jem.20141759","volume":"211","author":"CL Lucas","year":"2014","unstructured":"Lucas, C. L. et al. Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K. J. Exp. Med. 211, 2537\u20132547 (2014).","journal-title":"J. Exp. Med."},{"key":"520_CR125","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1084\/jem.20180010","volume":"215","author":"DT Avery","year":"2018","unstructured":"Avery, D. T. et al. Germline-activating mutations in PIK3CD compromise B cell development and function. J. Exp. Med. 215, 2073\u20132095 (2018).","journal-title":"J. Exp. Med."},{"key":"520_CR126","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.clim.2017.01.004","volume":"176","author":"M Wentink","year":"2017","unstructured":"Wentink, M. et al. Genetic defects in PI3Kdelta affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections. Clin. Immunol. 176, 77\u201386 (2017).","journal-title":"Clin. Immunol."},{"key":"520_CR127","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1172\/JCI120572","volume":"129","author":"A Bouafia","year":"2019","unstructured":"Bouafia, A. et al. Loss of ARHGEF1 causes a human primary antibody deficiency. J. Clin. Investig. 129, 1047\u20131060 (2019).","journal-title":"J. Clin. Investig."},{"key":"520_CR128","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1172\/JCI125893","volume":"129","author":"D Mathew","year":"2019","unstructured":"Mathew, D., Kremer, K. N. & Torres, R. M. ARHGEF1 deficiency reveals Galpha13-associated GPCRs are critical regulators of human lymphocyte function. J. Clin. Investig. 129, 965\u2013968 (2019).","journal-title":"J. Clin. Investig."},{"key":"520_CR129","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/j.jaci.2016.03.055","volume":"138","author":"Y Tsujita","year":"2016","unstructured":"Tsujita, Y. et al. Phosphatase and tensin homolog (PTEN) mutation can cause activated phosphatidylinositol 3-kinase delta syndrome-like immunodeficiency. J. Allergy Clin. Immunol. 138, 1672\u20131680 e1610 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR130","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1136\/jmedgenet-2015-103266","volume":"52","author":"MJ Browning","year":"2015","unstructured":"Browning, M. J., Chandra, A., Carbonaro, V., Okkenhaug, K. & Barwell, J. Cowden\u2019s syndrome with immunodeficiency. J. Med. Genet. 52, 856\u2013859 (2015).","journal-title":"J. Med. Genet."},{"key":"520_CR131","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1073\/pnas.1617244114","volume":"114","author":"GL Dornan","year":"2017","unstructured":"Dornan, G. L. et al. Conformational disruption of PI3Kdelta regulation by immunodeficiency mutations in PIK3CD and PIK3R1. Proc. Natl Acad. Sci. USA 114, 1982\u20131987 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"520_CR132","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jaci.2016.10.054","volume":"140","author":"M Kaustio","year":"2017","unstructured":"Kaustio, M. et al. Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes. J. Allergy Clin. Immunol. 140, 782\u2013796 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR133","unstructured":"Lorenzini, T. et al. Characterization of the clinical and immunological phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations. J Allergy Clin. Immunol. (2020). (In press)"},{"key":"520_CR134","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.jaci.2018.01.039","volume":"142","author":"P Tuijnenburg","year":"2018","unstructured":"Tuijnenburg, P. et al. Loss-of-function nuclear factor kappaB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans. J. Allergy Clin. Immunol. 142, 1285\u20131296 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR135","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1182\/blood-2017-05-782177","volume":"130","author":"HS Kuehn","year":"2017","unstructured":"Kuehn, H. S. et al. Novel nonsense gain-of-function NFKB2 mutations associated with a combined immunodeficiency phenotype. Blood 130, 1553\u20131564 (2017).","journal-title":"Blood"},{"key":"520_CR136","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10875-016-0306-1","volume":"36","author":"H Boztug","year":"2016","unstructured":"Boztug, H. et al. NF-kappaB1 haploinsufficiency causing immunodeficiency and ebv-driven lymphoproliferation. J. Clin. Immunol. 36, 533\u2013540 (2016).","journal-title":"J. Clin. Immunol."},{"key":"520_CR137","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ajhg.2015.07.008","volume":"97","author":"M Fliegauf","year":"2015","unstructured":"Fliegauf, M. et al. Haploinsufficiency of the NF-kappaB1 subunit p50 in common variable immunodeficiency. Am. J. Hum. Genet. 97, 389\u2013403 (2015).","journal-title":"Am. J. Hum. Genet."},{"key":"520_CR138","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3389\/fped.2019.00303","volume":"7","author":"A Aird","year":"2019","unstructured":"Aird, A. et al. Novel heterozygous mutation in NFKB2 is associated with early onset CVID and a functional defect in NK cells complicated by disseminated CMV infection and severe nephrotic syndrome. Front. Pediatr. 7, 303 (2019).","journal-title":"Front. Pediatr."},{"key":"520_CR139","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-014-0139-9","volume":"15","author":"T Brue","year":"2014","unstructured":"Brue, T. et al. Mutations in NFKB2 and potential genetic heterogeneity in patients with DAVID syndrome, having variable endocrine and immune deficiencies. BMC Med. Genet. 15, 139 (2014).","journal-title":"BMC Med. Genet."},{"key":"520_CR140","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.ajhg.2013.09.009","volume":"93","author":"K Chen","year":"2013","unstructured":"Chen, K. et al. Germline mutations in NFKB2 implicate the noncanonical NF-kappaB pathway in the pathogenesis of common variable immunodeficiency. Am. J. Hum. Genet. 93, 812\u2013824 (2013).","journal-title":"Am. J. Hum. Genet."},{"key":"520_CR141","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fimmu.2019.00297","volume":"10","author":"C Klemann","year":"2019","unstructured":"Klemann, C. et al. Clinical and immunological phenotype of patients with primary immunodeficiency due to damaging mutations in NFKB2. Front. Immunol. 10, 297 (2019).","journal-title":"Front. Immunol."},{"key":"520_CR142","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1182\/blood-2014-06-578542","volume":"124","author":"CE Lee","year":"2014","unstructured":"Lee, C. E. et al. Autosomal-dominant B-cell deficiency with alopecia due to a mutation in NFKB2 that results in nonprocessable p100. Blood 124, 2964\u20132972 (2014).","journal-title":"Blood"},{"key":"520_CR143","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1007\/s10875-014-0095-3","volume":"34","author":"AW Lindsley","year":"2014","unstructured":"Lindsley, A. W. et al. Combined immune deficiency in a patient with a novel NFKB2 mutation. J. Clin. Immunol. 34, 910\u2013915 (2014).","journal-title":"J. Clin. Immunol."},{"key":"520_CR144","doi-asserted-by":"publisher","first-page":"e5081","DOI":"10.1097\/MD.0000000000005081","volume":"95","author":"C Shi","year":"2016","unstructured":"Shi, C. et al. NFKB2 mutation in common variable immunodeficiency and isolated adrenocorticotropic hormone deficiency: a case report and review of literature. Medicine 95, e5081 (2016).","journal-title":"Medicine"},{"key":"520_CR145","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1126\/science.1243292","volume":"342","author":"I Angulo","year":"2013","unstructured":"Angulo, I. et al. Phosphoinositide 3-kinase delta gene mutation predisposes to respiratory infection and airway damage. Science 342, 866\u2013871 (2013).","journal-title":"Science"},{"key":"520_CR146","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","volume":"139","author":"TI Coulter","year":"2017","unstructured":"Coulter, T. I. et al. Clinical spectrum and features of activated phosphoinositide 3-kinase delta syndrome: a large patient cohort study. J. Allergy Clin. Immunol. 139, 597\u2013606.e594 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR147","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nri.2016.93","volume":"16","author":"CL Lucas","year":"2016","unstructured":"Lucas, C. L., Chandra, A., Nejentsev, S., Condliffe, A. M. & Okkenhaug, K. PI3Kdelta and primary immunodeficiencies. Nat. Rev. Immunol. 16, 702\u2013714 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"520_CR148","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ni.2771","volume":"15","author":"CL Lucas","year":"2014","unstructured":"Lucas, C. L. et al. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110delta result in T cell senescence and human immunodeficiency. Nat. Immunol. 15, 88\u201397 (2014).","journal-title":"Nat. Immunol."},{"key":"520_CR149","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/imr.12790","volume":"291","author":"S Preite","year":"2019","unstructured":"Preite, S., Gomez-Rodriguez, J., Cannons, J. L. & Schwartzberg, P. L. T and B-cell signaling in activated PI3K delta syndrome: from immunodeficiency to autoimmunity. Immunol. Rev. 291, 154\u2013173 (2019).","journal-title":"Immunol. Rev."},{"key":"520_CR150","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jaci.2019.01.033","volume":"144","author":"J Bier","year":"2019","unstructured":"Bier, J. et al. Activating mutations in PIK3CD disrupt the differentiation and function of human and murine CD4(+) T cells. J. Allergy Clin. Immunol. 144, 236\u2013253 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR151","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jaci.2018.04.030","volume":"143","author":"ESJ Edwards","year":"2019","unstructured":"Edwards, E. S. J. et al. Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunity. J. Allergy Clin. Immunol. 143, 276\u2013291.e276 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR152","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.jaci.2017.11.042","volume":"142","author":"R Ruiz-Garcia","year":"2018","unstructured":"Ruiz-Garcia, R. et al. Mutations in PI3K110delta cause impaired natural killer cell function partially rescued by rapamycin treatment. J. Allergy Clin. Immunol. 142, 605\u2013617.e607 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"Suppl 1","key":"520_CR153","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1002\/cyto.b.20547","volume":"78","author":"M Perez-Andres","year":"2010","unstructured":"Perez-Andres, M. et al. Human peripheral blood B-cell compartments: a crossroad in B-cell traffic. Cytom. B Clin. Cytom. 78(Suppl 1), S47\u2013S60 (2010).","journal-title":"Cytom. B Clin. Cytom."},{"key":"520_CR154","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ajhg.2016.05.028","volume":"99","author":"NA Bolar","year":"2016","unstructured":"Bolar, N. A. et al. Heterozygous loss-of-function SEC61A1 mutations cause autosomal-dominant tubulo-interstitial and glomerulocystic kidney disease with anemia. Am. J. Hum. Genet. 99, 174\u2013187 (2016).","journal-title":"Am. J. Hum. Genet"},{"key":"520_CR155","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.jaci.2017.06.042","volume":"141","author":"D Schubert","year":"2018","unstructured":"Schubert, D. et al. Plasma cell deficiency in human subjects with heterozygous mutations in Sec61 translocon alpha 1 subunit (SEC61A1). J. Allergy Clin. Immunol. 141, 1427\u20131438 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR156","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.jaci.2016.01.018","volume":"138","author":"MD Keller","year":"2016","unstructured":"Keller, M. D. et al. Mutation in IRF2BP2 is responsible for a familial form of common variable immunodeficiency disorder. J. Allergy Clin. Immunol. 138, 544\u2013550 e544 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR157","unstructured":"Yeh, T. W. O., et al. APRIL-dependent life-long plasmacyte maintenance and immunoglobulin production in humans. J. Allergy Clin. Immunol. S0091-6749(20)30432-2 (2020). [Epub ahead of print]."},{"key":"520_CR158","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1056\/NEJMoa1302846","volume":"370","author":"MA Sadat","year":"2014","unstructured":"Sadat, M. A. et al. Glycosylation, hypogammaglobulinemia, and resistance to viral infections. N. Engl. J. Med. 370, 1615\u20131625 (2014).","journal-title":"N. Engl. J. Med."},{"key":"520_CR159","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1542\/peds.9.6.722","volume":"9","author":"OC Bruton","year":"1952","unstructured":"Bruton, O. C. Agammaglobulinemia. Pediatrics 9, 722\u2013728 (1952).","journal-title":"Pediatrics"},{"key":"520_CR160","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jaci.2019.09.009","volume":"145","author":"IK Chinn","year":"2020","unstructured":"Chinn, I. K. et al. Diagnostic interpretation of genetic studies in patients with primary immunodeficiency diseases: a working group report of the Primary Immunodeficiency Diseases Committee of the American Academy of Allergy, Asthma & Immunology. J. Allergy Clin. Immunol. 145, 46\u201369 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR161","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.jaci.2016.08.003","volume":"138","author":"I Meyts","year":"2016","unstructured":"Meyts, I. et al. Exome and genome sequencing for inborn errors of immunity. J. Allergy Clin. Immunol. 138, 957\u2013969 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR162","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3389\/fimmu.2015.00142","volume":"6","author":"Y Itan","year":"2015","unstructured":"Itan, Y. & Casanova, J. L. Novel primary immunodeficiency candidate genes predicted by the human gene connectome. Front. Immunol. 6, 142 (2015).","journal-title":"Front. Immunol."},{"key":"520_CR163","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jmoldx.2016.07.006","volume":"18","author":"W Mu","year":"2016","unstructured":"Mu, W., Lu, H. M., Chen, J., Li, S. & Elliott, A. M. Sanger confirmation is required to achieve optimal sensitivity and specificity in next-generation sequencing panel testing. J. Mol. Diagn. 18, 923\u2013932 (2016).","journal-title":"J. Mol. Diagn."},{"key":"520_CR164","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1126\/science.1084564","volume":"300","author":"FS Collins","year":"2003","unstructured":"Collins, F. S., Morgan, M. & Patrinos, A. The Human Genome Project: lessons from large-scale biology. Science 300, 286\u2013290 (2003).","journal-title":"Science"},{"key":"520_CR165","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nature03001","volume":"431","author":"C International Human Genome Sequenci","year":"2004","unstructured":"International Human Genome Sequencing, C. Finishing the euchromatic sequence of the human genome. Nature 431, 931\u2013945 (2004).","journal-title":"Nature"},{"issue":"Suppl 1","key":"520_CR166","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s10875-016-0260-y","volume":"36","author":"M Fang","year":"2016","unstructured":"Fang, M., Abolhassani, H., Lim, C. K., Zhang, J. & Hammarstrom, L. Next generation sequencing data analysis in primary immunodeficiency disorders\u2014future directions. J. Clin. Immunol. 36(Suppl 1), 68\u201375 (2016).","journal-title":"J. Clin. Immunol."},{"key":"520_CR167","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.coi.2014.05.004","volume":"30","author":"ME Conley","year":"2014","unstructured":"Conley, M. E. & Casanova, J. L. Discovery of single-gene inborn errors of immunity by next generation sequencing. Curr. Opin. Immunol. 30, 17\u201323 (2014).","journal-title":"Curr. Opin. Immunol."},{"key":"520_CR168","doi-asserted-by":"publisher","first-page":"S297","DOI":"10.1016\/j.jaci.2009.08.043","volume":"125","author":"JB Oliveira","year":"2010","unstructured":"Oliveira, J. B. & Fleisher, T. A. Laboratory evaluation of primary immunodeficiencies. J. Allergy Clin. Immunol. 125, S297\u2013S305 (2010).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR169","doi-asserted-by":"publisher","first-page":"e114901","DOI":"10.1371\/journal.pone.0114901","volume":"9","author":"LN Moens","year":"2014","unstructured":"Moens, L. N. et al. Diagnostics of primary immunodeficiency diseases: a sequencing capture approach. PLoS ONE 9, e114901 (2014).","journal-title":"PLoS ONE"},{"key":"520_CR170","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jaci.2013.08.032","volume":"133","author":"IJ Nijman","year":"2014","unstructured":"Nijman, I. J. et al. Targeted next-generation sequencing: a novel diagnostic tool for primary immunodeficiencies. J. Allergy Clin. Immunol. 133, 529\u2013534 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR171","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3389\/fimmu.2014.00531","volume":"5","author":"JL Stoddard","year":"2014","unstructured":"Stoddard, J. L., Niemela, J. E., Fleisher, T. A. & Rosenzweig, S. D. Targeted NGS: a cost-effective approach to molecular diagnosis of PIDs. Front. Immunol. 5, 531 (2014).","journal-title":"Front. Immunol."},{"key":"520_CR172","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/ACI.0b013e3283588ca6","volume":"12","author":"J Chou","year":"2012","unstructured":"Chou, J., Ohsumi, T. K. & Geha, R. S. Use of whole exome and genome sequencing in the identification of genetic causes of primary immunodeficiencies. Curr. Opin. Allergy Clin. Immunol. 12, 623\u2013628 (2012).","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"520_CR173","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nrg3031","volume":"12","author":"MJ Bamshad","year":"2011","unstructured":"Bamshad, M. J. et al. Exome sequencing as a tool for Mendelian disease gene discovery. Nat. Rev. Genet. 12, 745\u2013755 (2011).","journal-title":"Nat. Rev. Genet."},{"key":"520_CR174","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1038\/ng.2007.42","volume":"39","author":"E Hodges","year":"2007","unstructured":"Hodges, E. et al. Genome-wide in situ exon capture for selective resequencing. Nat. Genet. 39, 1522\u20131527 (2007).","journal-title":"Nat. Genet."},{"key":"520_CR175","doi-asserted-by":"publisher","first-page":"23","DOI":"10.20517\/jtgg.2017.04","volume":"1","author":"L Dyer","year":"2017","unstructured":"Dyer, L. et al. Gene dosage defects in primary immunodeficiencies and related disorders: a pilot study. J. Transl. Genet. Genom. 1, 23\u201327 (2017).","journal-title":"J. Transl. Genet. Genom."},{"key":"520_CR176","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41586-020-2265-1","volume":"583","author":"JED Thaventhiran","year":"2020","unstructured":"Thaventhiran, J. E. D. et al. Whole-genome sequencing of a sporadic primary immunodeficiency cohort. Nature 583, 90\u201395 (2020).","journal-title":"Nature"},{"key":"520_CR177","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1073\/pnas.1418631112","volume":"112","author":"A Belkadi","year":"2015","unstructured":"Belkadi, A. et al. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants. Proc. Natl Acad. Sci. USA 112, 5473\u20135478 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"520_CR178","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285\u2013291 (2016).","journal-title":"Nature"},{"key":"520_CR179","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013424 (2015).","journal-title":"Genet. Med."},{"key":"520_CR180","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00439-013-1358-4","volume":"133","author":"PD Stenson","year":"2014","unstructured":"Stenson, P. D. et al. The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum. Genet. 133, 1\u20139 (2014).","journal-title":"Hum. Genet"},{"key":"520_CR181","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2144\/000114492","volume":"62","author":"M Jalali Sefid Dashti","year":"2017","unstructured":"Jalali Sefid Dashti, M. & Gamieldien, J. A practical guide to filtering and prioritizing genetic variants. Biotechniques 62, 18\u201330 (2017).","journal-title":"Biotechniques"},{"key":"520_CR182","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-017-0403-7","volume":"9","author":"Y Kobayashi","year":"2017","unstructured":"Kobayashi, Y. et al. Pathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation. Genome Med. 9, 13 (2017).","journal-title":"Genome Med."},{"key":"520_CR183","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1084\/jem.20140520","volume":"211","author":"JL Casanova","year":"2014","unstructured":"Casanova, J. L., Conley, M. E., Seligman, S. J., Abel, L. & Notarangelo, L. D. Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies. J. Exp. Med. 211, 2137\u20132149 (2014).","journal-title":"J. Exp. Med."},{"key":"520_CR184","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nprot.2009.86","volume":"4","author":"P Kumar","year":"2009","unstructured":"Kumar, P., Henikoff, S. & Ng, P. C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4, 1073\u20131081 (2009).","journal-title":"Nat. Protoc."},{"key":"520_CR185","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei, I. A. et al. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248\u2013249 (2010).","journal-title":"Nat. Methods"},{"key":"520_CR186","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.smim.2017.12.001","volume":"36","author":"A Fischer","year":"2018","unstructured":"Fischer, A. & Rausell, A. What do primary immunodeficiencies tell us about the essentiality\/redundancy of immune responses? Semin. Immunol. 36, 13\u201316 (2018).","journal-title":"Semin. Immunol."},{"key":"520_CR187","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.coi.2019.03.008","volume":"59","author":"SY Zhang","year":"2019","unstructured":"Zhang, S. Y. et al. Human inborn errors of immunity to infection affecting cells other than leukocytes: from the immune system to the whole organism. Curr. Opin. Immunol. 59, 88\u2013100 (2019).","journal-title":"Curr. Opin. Immunol."},{"key":"520_CR188","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/ng.3898","volume":"49","author":"CA Ma","year":"2017","unstructured":"Ma, C. A. et al. Germline hypomorphic CARD11 mutations in severe atopic disease. Nat. Genet. 49, 1192\u20131201 (2017).","journal-title":"Nat. Genet"},{"key":"520_CR189","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jaci.2015.03.005","volume":"136","author":"K Felgentreff","year":"2015","unstructured":"Felgentreff, K. et al. Functional analysis of naturally occurring DCLRE1C mutations and correlation with the clinical phenotype of ARTEMIS deficiency. J. Allergy Clin. Immunol. 136, 140\u2013150.e147 (2015).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR190","first-page":"3","volume":"40","author":"F Gutierrez-Rodrigues","year":"2018","unstructured":"Gutierrez-Rodrigues, F. & Calado, R. T. The interpretation of rare or novel variants: damaging vs. disease-causing. Rev. Bras. Hematol. Hemoter. 40, 3\u20134 (2018).","journal-title":"Rev. Bras. Hematol. Hemoter."},{"key":"520_CR191","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3389\/fimmu.2016.00466","volume":"7","author":"V Gallo","year":"2016","unstructured":"Gallo, V. et al. Diagnostics of primary immunodeficiencies through next-generation sequencing. Front. Immunol. 7, 466 (2016).","journal-title":"Front. Immunol."},{"key":"520_CR192","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.clim.2015.05.020","volume":"160","author":"PA van Schouwenburg","year":"2015","unstructured":"van Schouwenburg, P. A. et al. Application of whole genome and RNA sequencing to investigate the genomic landscape of common variable immunodeficiency disorders. Clin. Immunol. 160, 301\u2013314 (2015).","journal-title":"Clin. Immunol."},{"key":"520_CR193","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3389\/fimmu.2018.00636","volume":"9","author":"G de Valles-Ibanez","year":"2018","unstructured":"de Valles-Ibanez, G. et al. Evaluating the genetics of common variable immunodeficiency: monogenetic model and beyond. Front. Immunol. 9, 636 (2018).","journal-title":"Front. Immunol."},{"key":"520_CR194","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.3389\/fimmu.2019.03022","volume":"10","author":"M Christiansen","year":"2019","unstructured":"Christiansen, M. et al. Identification of novel genetic variants in CVID patients with autoimmunity, autoinflammation, or malignancy. Front. Immunol. 10, 3022 (2019).","journal-title":"Front. Immunol."},{"key":"520_CR195","doi-asserted-by":"publisher","DOI":"10.1038\/srep39710","volume":"7","author":"J Stuchly","year":"2017","unstructured":"Stuchly, J. et al. Common Variable Immunodeficiency patients with a phenotypic profile of immunosenescence present with thrombocytopenia. Sci. Rep. 7, 39710 (2017).","journal-title":"Sci. Rep."},{"key":"520_CR196","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fimmu.2016.00220","volume":"7","author":"P Maffucci","year":"2016","unstructured":"Maffucci, P. et al. Genetic diagnosis using whole exome sequencing in common variable immunodeficiency. Front. Immunol. 7, 220 (2016).","journal-title":"Front. Immunol."},{"key":"520_CR197","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41436-018-0012-x","volume":"21","author":"H Abolhassani","year":"2019","unstructured":"Abolhassani, H. et al. Clinical implications of systematic phenotyping and exome sequencing in patients with primary antibody deficiency. Genet. Med. 21, 243\u2013251 (2019).","journal-title":"Genet. Med."},{"key":"520_CR198","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.jaci.2018.02.055","volume":"142","author":"C Schwab","year":"2018","unstructured":"Schwab, C. et al. Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects. J. Allergy Clin. Immunol. 142, 1932\u20131946 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR199","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1828-7","volume":"20","author":"M Mahmoud","year":"2019","unstructured":"Mahmoud, M. et al. Structural variant calling: the long and the short of it. Genome Biol. 20, 246 (2019).","journal-title":"Genome Biol."},{"key":"520_CR200","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/cei.12255","volume":"177","author":"M Keller","year":"2014","unstructured":"Keller, M. et al. Burden of copy number variation in common variable immunodeficiency. Clin. Exp. Immunol. 177, 269\u2013271 (2014).","journal-title":"Clin. Exp. Immunol."},{"key":"520_CR201","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jaci.2016.05.042","volume":"139","author":"A Stray-Pedersen","year":"2017","unstructured":"Stray-Pedersen, A. et al. Primary immunodeficiency diseases: genomic approaches delineate heterogeneous Mendelian disorders. J. Allergy Clin. Immunol. 139, 232\u2013245 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR202","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.jaci.2011.02.039","volume":"127","author":"JS Orange","year":"2011","unstructured":"Orange, J. S. et al. Genome-wide association identifies diverse causes of common variable immunodeficiency. J. Allergy Clin. Immunol. 127, 1360\u20131367.e1366 (2011).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR203","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/ng1885","volume":"38","author":"PI de Bakker","year":"2006","unstructured":"de Bakker, P. I. et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat. Genet. 38, 1166\u20131172 (2006).","journal-title":"Nat. Genet."},{"key":"520_CR204","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7804","volume":"6","author":"J Li","year":"2015","unstructured":"Li, J. et al. Association of CLEC16A with human common variable immunodeficiency disorder and role in murine B cells. Nat. Commun. 6, 6804 (2015).","journal-title":"Nat. Commun."},{"key":"520_CR205","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.coi.2014.09.007","volume":"31","author":"V Kumar","year":"2014","unstructured":"Kumar, V., Wijmenga, C. & Xavier, R. J. Genetics of immune-mediated disorders: from genome-wide association to molecular mechanism. Curr. Opin. Immunol. 31, 51\u201357 (2014).","journal-title":"Curr. Opin. Immunol."},{"key":"520_CR206","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/cei.13101","volume":"193","author":"T David","year":"2018","unstructured":"David, T., Ling, S. F. & Barton, A. Genetics of immune-mediated inflammatory diseases. Clin. Exp. Immunol. 193, 3\u201312 (2018).","journal-title":"Clin. Exp. Immunol."},{"key":"520_CR207","doi-asserted-by":"publisher","first-page":"10653","DOI":"10.1073\/pnas.89.22.10653","volume":"89","author":"O Olerup","year":"1992","unstructured":"Olerup, O., Smith, C. I., Bjorkander, J. & Hammarstrom, L. Shared HLA class II-associated genetic susceptibility and resistance, related to the HLA-DQB1 gene, in IgA deficiency and common variable immunodeficiency. Proc. Natl Acad. Sci. USA 89, 10653\u201310657 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"520_CR208","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.jaci.2014.12.1939","volume":"135","author":"SM Maggadottir","year":"2015","unstructured":"Maggadottir, S. M. et al. Rare variants at 16p11.2 are associated with common variable immunodeficiency. J. Allergy Clin. Immunol. 135, 1569\u20131577 (2015).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR209","doi-asserted-by":"publisher","first-page":"26506","DOI":"10.1074\/jbc.M110.111104","volume":"285","author":"E Fiorillo","year":"2010","unstructured":"Fiorillo, E. et al. Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue. J. Biol. Chem. 285, 26506\u201326518 (2010).","journal-title":"J. Biol. Chem."},{"key":"520_CR210","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.jaci.2012.06.023","volume":"131","author":"GY Chew","year":"2013","unstructured":"Chew, G. Y. et al. Autoimmunity in primary antibody deficiency is associated with protein tyrosine phosphatase nonreceptor type 22 (PTPN22). J. Allergy Clin. Immunol. 131, 1130\u20131135.1135.e1131 (2013).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR211","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.3389\/fimmu.2019.02434","volume":"10","author":"T Kalina","year":"2019","unstructured":"Kalina, T. et al. CD maps-dynamic profiling of CD1-CD100 surface expression on human leukocyte and lymphocyte subsets. Front. Immunol. 10, 2434 (2019).","journal-title":"Front. Immunol."},{"key":"520_CR212","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3389\/fimmu.2019.00895","volume":"10","author":"MC van Zelm","year":"2019","unstructured":"van Zelm, M. C. et al. Functional antibody responses following allogeneic stem cell transplantation for TP53 mutant pre-B-ALL in a patient with X-linked agammaglobulinemia. Front. Immunol. 10, 895 (2019).","journal-title":"Front. Immunol."},{"key":"520_CR213","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1365-2230.2007.02592.x","volume":"111","author":"HB Gaspar","year":"1998","unstructured":"Gaspar, H. B., Lester, T., Levinsky, R. J. & Kinnon, C. Bruton\u2019s tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA. Clin. Exp. Immunol. 111, 334\u2013338 (1998).","journal-title":"Clin. Exp. Immunol."},{"key":"520_CR214","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1084\/jem.20160849","volume":"214","author":"H Abolhassani","year":"2017","unstructured":"Abolhassani, H. et al. Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency. J. Exp. Med. 214, 91\u2013106 (2017).","journal-title":"J. Exp. Med."},{"key":"520_CR215","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.3389\/fimmu.2017.02015","volume":"8","author":"R Caorsi","year":"2017","unstructured":"Caorsi, R. et al. CD70 deficiency due to a novel mutation in a patient with severe chronic EBV infection presenting as a periodic fever. Front. Immunol. 8, 2015 (2017).","journal-title":"Front. Immunol."},{"key":"520_CR216","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1084\/jem.20160784","volume":"214","author":"K Izawa","year":"2017","unstructured":"Izawa, K. et al. Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection. J. Exp. Med. 214, 73\u201389 (2017).","journal-title":"J. Exp. Med."},{"key":"520_CR217","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.ajhg.2012.04.015","volume":"90","author":"G Lopez-Herrera","year":"2012","unstructured":"Lopez-Herrera, G. et al. Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. Am. J. Hum. Genet. 90, 986\u20131001 (2012).","journal-title":"Am. J. Hum. Genet."},{"key":"520_CR218","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.4049\/jimmunol.1600954","volume":"199","author":"EB Okeke","year":"2017","unstructured":"Okeke, E. B. et al. Deficiency of phosphatidylinositol 3-kinase delta signaling leads to diminished numbers of regulatory T cells and increased neutrophil activity resulting in mortality due to endotoxic shock. J. Immunol. 199, 1086\u20131095 (2017).","journal-title":"J. Immunol."},{"key":"520_CR219","doi-asserted-by":"crossref","unstructured":"Edwards, E. S. J., et al. Predominantly antibody-deficient patients with non-infectious complications have reduced naive B, Treg, Th17 and Tfh17 cells. Front. Immunol. (2019).","DOI":"10.3389\/fimmu.2019.02593"},{"key":"520_CR220","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","volume":"27","author":"EJ Wherry","year":"2007","unstructured":"Wherry, E. J. et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27, 670\u2013684 (2007).","journal-title":"Immunity"},{"key":"520_CR221","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.3390\/ijms18081742","volume":"18","author":"W Xu","year":"2017","unstructured":"Xu, W. & Larbi, A. Markers of T cell senescence in humans. Int. J. Mol. Sci. 18, 1742 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"520_CR222","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1128\/CDLI.7.6.859-864.2000","volume":"7","author":"N Bercovici","year":"2000","unstructured":"Bercovici, N., Duffour, M. T., Agrawal, S., Salcedo, M. & Abastado, J. P. New methods for assessing T-cell responses. Clin. Diagn. Lab. Immunol. 7, 859\u2013864 (2000).","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"520_CR223","unstructured":"Ghosh, S. et al. Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiency. Blood (2020). [Epub ahead of print]."},{"key":"520_CR224","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1128\/JVI.03422-13","volume":"88","author":"JR Whittle","year":"2014","unstructured":"Whittle, J. R. et al. Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages. J. Virol. 88, 4047\u20134057 (2014).","journal-title":"J. Virol."},{"key":"520_CR225","doi-asserted-by":"publisher","DOI":"10.1038\/srep26478","volume":"6","author":"AK Wheatley","year":"2016","unstructured":"Wheatley, A. K., Kristensen, A. B., Lay, W. N. & Kent, S. J. HIV-dependent depletion of influenza-specific memory B cells impacts B cell responsiveness to seasonal influenza immunisation. Sci. Rep. 6, 26478 (2016).","journal-title":"Sci. Rep."},{"key":"520_CR226","doi-asserted-by":"crossref","unstructured":"Hartley, G. E., et al. Influenza-specific IgG1+ memory B cell numbers increase upon booster vaccination in healthy adults but not in patients with Predominantly Antibody Deficiency. Under review (2020).","DOI":"10.1002\/cti2.1199"},{"key":"520_CR227","doi-asserted-by":"publisher","first-page":"4234","DOI":"10.1182\/blood.V84.12.4234.bloodjournal84124234","volume":"84","author":"MB Fischer","year":"1994","unstructured":"Fischer, M. B. et al. A defect in the early phase of T-cell receptor-mediated T-cell activation in patients with common variable immunodeficiency. Blood 84, 4234\u20134241 (1994).","journal-title":"Blood"},{"key":"520_CR228","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nature10246","volume":"475","author":"FY Li","year":"2011","unstructured":"Li, F. Y. et al. Second messenger role for Mg2+ revealed by human T-cell immunodeficiency. Nature 475, 471\u2013476 (2011).","journal-title":"Nature"},{"key":"520_CR229","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1126\/science.1240094","volume":"341","author":"B Chaigne-Delalande","year":"2013","unstructured":"Chaigne-Delalande, B. et al. Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D. Science 341, 186\u2013191 (2013).","journal-title":"Science"},{"key":"520_CR230","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/978-1-4939-7346-0_12","volume":"1678","author":"JD Tario Jr.","year":"2018","unstructured":"Tario, J. D. Jr., Conway, A. N., Muirhead, K. A. & Wallace, P. K. Monitoring cell proliferation by dye dilution: considerations for probe selection. Methods Mol. Biol. 1678, 249\u2013299 (2018).","journal-title":"Methods Mol. Biol."},{"key":"520_CR231","first-page":"473","volume":"56","author":"MA French","year":"1984","unstructured":"French, M. A. & Harrison, G. Serum IgG subclass concentrations in healthy adults: a study using monoclonal antisera. Clin. Exp. Immunol. 56, 473\u2013475 (1984).","journal-title":"Clin. Exp. Immunol."},{"key":"520_CR232","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1128\/IAI.66.9.4163-4168.1998","volume":"66","author":"A Berneman","year":"1998","unstructured":"Berneman, A., Belec, L., Fischetti, V. A. & Bouvet, J. P. The specificity patterns of human immunoglobulin G antibodies in serum differ from those in autologous secretions. Infect. Immun. 66, 4163\u20134168 (1998).","journal-title":"Infect. Immun."},{"key":"520_CR233","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10875-019-00732-2","volume":"40","author":"EM Klinken","year":"2020","unstructured":"Klinken, E. M. et al. Diversity of XMEN disease: description of 2 novel variants and analysis of the lymphocyte phenotype. J. Clin. Immunol. 40, 299\u2013309 (2020).","journal-title":"J. Clin. Immunol."},{"key":"520_CR234","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1002\/eji.200939722","volume":"39","author":"F Sallusto","year":"2009","unstructured":"Sallusto, F. & Lanzavecchia, A. Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity. Eur. J. Immunol. 39, 2076\u20132082 (2009).","journal-title":"Eur. J. Immunol."},{"key":"520_CR235","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.3389\/fimmu.2018.02043","volume":"9","author":"TI Coulter","year":"2018","unstructured":"Coulter, T. I. & Cant, A. J. The treatment of activated PI3Kdelta syndrome. Front Immunol. 9, 2043 (2018).","journal-title":"Front Immunol."},{"key":"520_CR236","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3389\/fimmu.2018.00543","volume":"9","author":"ME Maccari","year":"2018","unstructured":"Maccari, M. E. et al. Disease evolution and response to rapamycin in activated phosphoinositide 3-kinase delta syndrome: the European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase delta Syndrome Registry. Front. Immunol. 9, 543 (2018).","journal-title":"Front. Immunol."},{"key":"520_CR237","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1182\/blood-2017-08-801191","volume":"130","author":"VK Rao","year":"2017","unstructured":"Rao, V. K. et al. Effective \u201cactivated PI3Kdelta syndrome\u201d-targeted therapy with the PI3Kdelta inhibitor leniolisib. Blood 130, 2307\u20132316 (2017).","journal-title":"Blood"},{"key":"520_CR238","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.pupt.2017.08.008","volume":"46","author":"A Cahn","year":"2017","unstructured":"Cahn, A. et al. Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kdelta inhibitor under development for the treatment of COPD. Pulm. Pharm. Ther. 46, 69\u201377 (2017).","journal-title":"Pulm. Pharm. Ther."},{"key":"520_CR239","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1126\/science.1255904","volume":"345","author":"HS Kuehn","year":"2014","unstructured":"Kuehn, H. S. et al. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science 345, 1623\u20131627 (2014).","journal-title":"Science"},{"key":"520_CR240","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1126\/science.aaa1663","volume":"349","author":"B Lo","year":"2015","unstructured":"Lo, B. et al. Autoimmune disease. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy. Science 349, 436\u2013440 (2015).","journal-title":"Science"},{"key":"520_CR241","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/nm.3746","volume":"20","author":"D Schubert","year":"2014","unstructured":"Schubert, D. et al. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat. Med. 20, 1410\u20131416 (2014).","journal-title":"Nat. Med."},{"key":"520_CR242","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.jaci.2012.05.043","volume":"130","author":"A Alangari","year":"2012","unstructured":"Alangari, A. et al. LPS-responsive beige-like anchor (LRBA) gene mutation in a family with inflammatory bowel disease and combined immunodeficiency. J. Allergy Clin. Immunol. 130, 481\u2013488 e482 (2012).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR243","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.jaci.2012.07.035","volume":"130","author":"SO Burns","year":"2012","unstructured":"Burns, S. O. et al. LRBA gene deletion in a patient presenting with autoimmunity without hypogammaglobulinemia. J. Allergy Clin. Immunol. 130, 1428\u20131432 (2012).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR244","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.clim.2015.04.007","volume":"159","author":"S Revel-Vilk","year":"2015","unstructured":"Revel-Vilk, S. et al. Autoimmune lymphoproliferative syndrome-like disease in patients with LRBA mutation. Clin. Immunol. 159, 84\u201392 (2015).","journal-title":"Clin. Immunol."},{"key":"520_CR245","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jaci.2015.08.036","volume":"137","author":"S Lee","year":"2016","unstructured":"Lee, S. et al. Abatacept alleviates severe autoimmune symptoms in a patient carrying a de novo variant in CTLA-4. J. Allergy Clin. Immunol. 137, 327\u2013330 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR246","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s10875-018-0511-1","volume":"38","author":"EM van Leeuwen","year":"2018","unstructured":"van Leeuwen, E. M., Cuadrado, E., Gerrits, A. M., Witteveen, E. & de Bree, G. J. Treatment of Intracerebral Lesions with Abatacept in a CTLA4-Haploinsufficient Patient. J. Clin. Immunol. 38, 464\u2013467 (2018).","journal-title":"J. Clin. Immunol."},{"key":"520_CR247","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1084\/jem.20110958","volume":"208","author":"L Liu","year":"2011","unstructured":"Liu, L. et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J. Exp. Med. 208, 1635\u20131648 (2011).","journal-title":"J. Exp. Med."},{"key":"520_CR248","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMoa1100102","volume":"365","author":"FL van de Veerdonk","year":"2011","unstructured":"van de Veerdonk, F. L. et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N. Engl. J. Med. 365, 54\u201361 (2011).","journal-title":"N. Engl. J. Med."},{"key":"520_CR249","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.coi.2012.04.011","volume":"24","author":"S Boisson-Dupuis","year":"2012","unstructured":"Boisson-Dupuis, S. et al. Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes. Curr. Opin. Immunol. 24, 364\u2013378 (2012).","journal-title":"Curr. Opin. Immunol."},{"key":"520_CR250","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","volume":"127","author":"J Toubiana","year":"2016","unstructured":"Toubiana, J. et al. Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. Blood 127, 3154\u20133164 (2016).","journal-title":"Blood"},{"key":"520_CR251","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3389\/fimmu.2019.00768","volume":"10","author":"MC van Zelm","year":"2019","unstructured":"van Zelm, M. C. et al. Impaired STAT3-dependent upregulation of IL2Ralpha in B cells of a patient with a STAT1 gain-of-function mutation. Front. Immunol. 10, 768 (2019).","journal-title":"Front. Immunol."},{"key":"520_CR252","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.gene.2016.04.006","volume":"586","author":"R Kobbe","year":"2016","unstructured":"Kobbe, R. et al. Common variable immunodeficiency, impaired neurological development and reduced numbers of T regulatory cells in a 10-year-old boy with a STAT1 gain-of-function mutation. Gene 586, 234\u2013238 (2016).","journal-title":"Gene"},{"key":"520_CR253","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1038\/sj.onc.1203525","volume":"19","author":"CV Ramana","year":"2000","unstructured":"Ramana, C. V., Chatterjee-Kishore, M., Nguyen, H. & Stark, G. R. Complex roles of Stat1 in regulating gene expression. Oncogene 19, 2619\u20132627 (2000).","journal-title":"Oncogene"},{"key":"520_CR254","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.jaci.2018.07.020","volume":"142","author":"LR Forbes","year":"2018","unstructured":"Forbes, L. R. et al. Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations. J. Allergy Clin. Immunol. 142, 1665\u20131669 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR255","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.jaci.2014.12.1867","volume":"135","author":"E Higgins","year":"2015","unstructured":"Higgins, E. et al. Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation. J. Allergy Clin. Immunol. 135, 551\u2013553 (2015).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR256","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jaci.2018.02.045","volume":"142","author":"K Meesilpavikkai","year":"2018","unstructured":"Meesilpavikkai, K. et al. Baricitinib treatment in a patient with a gain-of-function mutation in signal transducer and activator of transcription 1 (STAT1). J. Allergy Clin. Immunol. 142, 328\u2013330 e322 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR257","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.jaci.2011.07.055","volume":"128","author":"M Rizzi","year":"2011","unstructured":"Rizzi, M. et al. Outcome of allogeneic stem cell transplantation in adults with common variable immunodeficiency. J. Allergy Clin. Immunol. 128, 1371\u20131374 e1372 (2011).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR258","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.jaci.2014.11.029","volume":"135","author":"C Wehr","year":"2015","unstructured":"Wehr, C. et al. Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency. J. Allergy Clin. Immunol. 135, 988\u2013997.e986 (2015).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR259","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1182\/blood-2017-09-807487","volume":"131","author":"TA Fox","year":"2018","unstructured":"Fox, T. A. et al. Successful outcome following allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency. Blood 131, 917\u2013931 (2018).","journal-title":"Blood"},{"key":"520_CR260","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/sj.bmt.1705557","volume":"39","author":"H Olkinuora","year":"2007","unstructured":"Olkinuora, H. et al. T cell regeneration in pediatric allogeneic stem cell transplantation. Bone Marrow Transpl. 39, 149\u2013156 (2007).","journal-title":"Bone Marrow Transpl."},{"key":"520_CR261","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1182\/blood.V69.2.369.369","volume":"69","author":"LG Lum","year":"1987","unstructured":"Lum, L. G. The kinetics of immune reconstitution after human marrow transplantation. Blood 69, 369\u2013380 (1987).","journal-title":"Blood"},{"key":"520_CR262","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.jaci.2015.12.1311","volume":"137","author":"S Naik","year":"2016","unstructured":"Naik, S. et al. Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes. J. Allergy Clin. Immunol. 137, 1498\u20131505 e1491 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR263","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3389\/fped.2019.00295","volume":"7","author":"R Castagnoli","year":"2019","unstructured":"Castagnoli, R., Delmonte, O. M., Calzoni, E. & Notarangelo, L. D. Hematopoietic stem cell transplantation in primary immunodeficiency diseases: current status and future perspectives. Front. Pediatr. 7, 295 (2019).","journal-title":"Front. Pediatr."},{"key":"520_CR264","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/j.jaci.2018.08.010","volume":"142","author":"RA Marsh","year":"2018","unstructured":"Marsh, R. A. et al. Practice pattern changes and improvements in hematopoietic cell transplantation for primary immunodeficiencies. J. Allergy Clin. Immunol. 142, 2004\u20132007 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR265","doi-asserted-by":"crossref","unstructured":"Gennery, A. R. et al. Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better? J. Allergy Clin. Immunol. 126, 602\u2013610.e601-611 (2010).","DOI":"10.1016\/j.jaci.2010.06.015"},{"key":"520_CR266","doi-asserted-by":"crossref","unstructured":"Bezu, L., Chuang, A. W., Liu, P., Kroemer, G. & Kepp, O. Immunological effects of epigenetic modifiers. Cancers 11 (2019).","DOI":"10.3390\/cancers11121911"},{"key":"520_CR267","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.it.2018.11.005","volume":"40","author":"E Campos-Sanchez","year":"2019","unstructured":"Campos-Sanchez, E. & Martinez-Cano, J. Del Pino Molina, L., Lopez-Granados, E. & Cobaleda, C. Epigenetic deregulation in human primary immunodeficiencies. Trends Immunol. 40, 49\u201365 (2019).","journal-title":"Trends Immunol."},{"key":"520_CR268","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3389\/fimmu.2019.00878","volume":"10","author":"L Del Pino-Molina","year":"2019","unstructured":"Del Pino-Molina, L. et al. Impaired CpG demethylation in common variable immunodeficiency associates with B cell phenotype and proliferation rate. Front. Immunol. 10, 878 (2019).","journal-title":"Front. Immunol."},{"key":"520_CR269","doi-asserted-by":"publisher","first-page":"R216","DOI":"10.1093\/hmg\/ddx275","volume":"26","author":"AJ Titus","year":"2017","unstructured":"Titus, A. J., Gallimore, R. M., Salas, L. A. & Christensen, B. C. Cell-type deconvolution from DNA methylation: a review of recent applications. Hum. Mol. Genet. 26, R216\u2013R224 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"520_CR270","doi-asserted-by":"publisher","first-page":"e74893","DOI":"10.1371\/journal.pone.0074893","volume":"8","author":"J Park","year":"2013","unstructured":"Park, J. et al. Interferon signature in the blood in inflammatory common variable immune deficiency. PLoS ONE 8, e74893 (2013).","journal-title":"PLoS ONE"},{"key":"520_CR271","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10545-018-0146-7","volume":"41","author":"RJ Rodenburg","year":"2018","unstructured":"Rodenburg, R. J. The functional genomics laboratory: functional validation of genetic variants. J. Inherit. Metab. Dis. 41, 297\u2013307 (2018).","journal-title":"J. Inherit. Metab. Dis."},{"key":"520_CR272","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1126\/science.3931219","volume":"230","author":"J Stavnezer-Nordgren","year":"1985","unstructured":"Stavnezer-Nordgren, J., Kekish, O. & Zegers, B. J. Molecular defects in a human immunoglobulin kappa chain deficiency. Science 230, 458\u2013461 (1985).","journal-title":"Science"},{"key":"520_CR273","first-page":"745","volume":"48","author":"A Bottaro","year":"1991","unstructured":"Bottaro, A., Cariota, U. & DeMarchi, M. & Carbonara, A.O. Pulsed-field electrophoresis screening for immunoglobulin heavy-chain constant-region (IGHC) multigene deletions and duplications. Am. J. Hum. Genet. 48, 745\u2013756 (1991).","journal-title":"Am. J. Hum. Genet"},{"key":"520_CR274","doi-asserted-by":"publisher","first-page":"12614","DOI":"10.1073\/pnas.221456898","volume":"98","author":"S Ferrari","year":"2001","unstructured":"Ferrari, S. et al. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc. Natl Acad. Sci. USA 98, 12614\u201312619 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"520_CR275","first-page":"673","volume":"33","author":"KH Zhang","year":"2013","unstructured":"Zhang, K. H., Marsh, A. & Jordan, R. M.B. Identification of a phosphoinositide 3-kinase (PI-3K) p110 delta (PIK3CD) deficient individual. J. Clin. Immunol. 33, 673\u2013674 (2013).","journal-title":"J. Clin. Immunol."},{"key":"520_CR276","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jaci.2011.11.013","volume":"129","author":"JM van Montfrans","year":"2012","unstructured":"van Montfrans, J. M. et al. CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia. J. Allergy Clin. Immunol. 129, 787\u2013793.e786 (2012).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR277","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1182\/blood-2012-10-460741","volume":"121","author":"E Salzer","year":"2013","unstructured":"Salzer, E. et al. B-cell deficiency and severe autoimmunity caused by deficiency of protein kinase C delta. Blood 121, 3112\u20133116 (2013).","journal-title":"Blood"},{"key":"520_CR278","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/j.jaci.2014.02.034","volume":"133","author":"E Salzer","year":"2014","unstructured":"Salzer, E. et al. Early-onset inflammatory bowel disease and common variable immunodeficiency-like disease caused by IL-21 deficiency. J. Allergy Clin. Immunol. 133, 1651\u20131659.e1612 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"520_CR279","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1084\/jem.20111229","volume":"210","author":"D Kotlarz","year":"2013","unstructured":"Kotlarz, D. et al. Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome. J. Exp. Med. 210, 433\u2013443 (2013).","journal-title":"J. Exp. Med."},{"key":"520_CR280","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1182\/blood-2012-08-439083","volume":"122","author":"DH Wiseman","year":"2013","unstructured":"Wiseman, D. H. et al. A novel syndrome of congenital sideroblastic anemia, B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD). Blood 122, 112\u2013123 (2013).","journal-title":"Blood"},{"key":"520_CR281","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.ajhg.2012.08.006","volume":"91","author":"Q Zhou","year":"2012","unstructured":"Zhou, Q. et al. A hypermorphic missense mutation in PLCG2, encoding phospholipase Cgamma2, causes a dominantly inherited autoinflammatory disease with immunodeficiency. Am. J. Hum. Genet. 91, 713\u2013720 (2012).","journal-title":"Am. J. Hum. Genet."}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-00520-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-00520-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-00520-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T17:06:40Z","timestamp":1650215200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-00520-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,17]]},"references-count":281,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["520"],"URL":"https:\/\/doi.org\/10.1038\/s41423-020-00520-8","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,17]]},"assertion":[{"value":"29 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}